DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT
- Written by PR Newswire Asia - Daily Bulletin Au RSS
- Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient
- The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in combination with standard-of-care blood pressure medication over 2 years
- Of the 286 adult patients dosed in...
Read more: DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT



